These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Synthesis of N-methyl-N-(2-propynyl)-benzylamine and its o-bromo- and o-chloro derivatives, monoamine oxidase inhibitors]. Simon IB; Vvedenskiĭ VP; Chekman IS Med Prom SSSR; 1966 Jan; 20(1):8-10. PubMed ID: 5984475 [No Abstract] [Full Text] [Related]
3. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B. Silvestri R; La Regina G; De Martino G; Artico M; Befani O; Palumbo M; Agostinelli E; Turini P J Med Chem; 2003 Mar; 46(6):917-20. PubMed ID: 12620068 [TBL] [Abstract][Full Text] [Related]
4. Selective monoamine oxidase inhibitors. 1. Compounds related to 4-aminophenethylamine. Florvall L; Ask AL; Ogren SO; Ross SB J Med Chem; 1978 Jan; 21(1):56-63. PubMed ID: 22755 [TBL] [Abstract][Full Text] [Related]
6. [Biosynthesis and metabolism of indolamines in the pineal organ of Lacerta (reptiles, larcertilians). II. Monoamine oxidase activity and incorporation of 3H-5-HTP and 3H-5-HT under normal and experimental conditions]. Collin JP; Meiniel A Z Zellforsch Mikrosk Anat; 1973 Dec; 145(3):331-61. PubMed ID: 4543951 [No Abstract] [Full Text] [Related]
7. Acetylenic and allenic derivatives of 2-(1-methylindolyl) methylamine as selective inhibitors of the monoamine oxidases A and B. Cruces MA; Elorriaga C; Fernandez Alvarez E; Lopez Chico MT; Nieto Lopez O Farmaco Sci; 1988; 43(7-8):567-73. PubMed ID: 3224706 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and molecular modelling of novel substituted-4,5-dihydro-(1H)-pyrazole derivatives as potent and highly selective monoamine oxidase-A inhibitors. Chimenti F; Bolasco A; Manna F; Secci D; Chimenti P; Granese A; Befani O; Turini P; Alcaro S; Ortuso F Chem Biol Drug Des; 2006 Mar; 67(3):206-14. PubMed ID: 16611214 [TBL] [Abstract][Full Text] [Related]
9. [Effect of peripheral serotonin antagonists and monoamine oxidase inhibitors on some central effects of indolalkylamines]. Gilev AP; Tetenchuk EV Farmakol Toksikol; 1968; 31(2):159-63. PubMed ID: 5674667 [No Abstract] [Full Text] [Related]
10. Synthesis and selective monoamine oxidase B-inhibiting properties of 1-methyl-1,2,3,6-tetrahydropyrid-4-yl carbamate derivatives: potential prodrugs of (R)- and (S)-nordeprenyl. Flaherty P; Castagnoli K; Wang YX; Castagnoli N J Med Chem; 1996 Nov; 39(24):4756-61. PubMed ID: 8941389 [TBL] [Abstract][Full Text] [Related]
11. Preparation and pharmacological screening of indanethylamines related to tryptamine. Data JB; Taylor ML; Forcione M J Pharm Sci; 1974 Jun; 63(6):848-53. PubMed ID: 4546886 [No Abstract] [Full Text] [Related]
12. [Effect of serotonin antagonists and monoamine oxidase inhibitors on the antineoplastic effect of serotonin]. Mal'tseva LF Farmakol Toksikol; 1968; 31(6):735-8. PubMed ID: 5713590 [No Abstract] [Full Text] [Related]
13. Amines and mouse thyroid activity: a thyroid-stimulating effect of 5-hydroxytryptamine and dopamine. Melander A Acta Endocrinol (Copenh); 1969 Nov; 62(3):565-76. PubMed ID: 4187716 [No Abstract] [Full Text] [Related]
14. Effects of co-administration of antidepressants and monoamine oxidase inhibitors on 5-HT-related behavior in rats. Izumi T; Iwamoto N; Kitaichi Y; Kato A; Inoue T; Koyama T Eur J Pharmacol; 2007 Jun; 565(1-3):105-12. PubMed ID: 17400208 [TBL] [Abstract][Full Text] [Related]
15. Allenic amines: a new class of nonhydrazine MAO inhibitors. Halliday RP; Davis CS; Heotis JP; Pals DT; Watson EJ; Bickerton RK J Pharm Sci; 1968 Mar; 57(3):430-3. PubMed ID: 5655581 [No Abstract] [Full Text] [Related]
16. Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane. Kumar Y; Florvall L; Ask AL; Ross SB; Holm AC; Ogren SO Acta Pharm Suec; 1983; 20(5):349-64. PubMed ID: 6666598 [No Abstract] [Full Text] [Related]
17. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain. Savage DD; Mendels J; Frazer A J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637 [TBL] [Abstract][Full Text] [Related]
18. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile. Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929 [TBL] [Abstract][Full Text] [Related]
19. Proceedings: Some considerations in the design of substrate and tissue specific inhibitors of MAO. Martin YC; Biel JH Psychopharmacol Bull; 1974 Jul; 10(3):8-9. PubMed ID: 4419448 [No Abstract] [Full Text] [Related]
20. (E)-2-(3,4-dimethoxyphenyl)-3-fluoroallylamine: a selective, enzyme-activated inhibitor of type B monoamine oxidase. Bey P; Fozard J; Lacoste JM; McDonald IA; Zreika M; Palfreyman MG J Med Chem; 1984 Jan; 27(1):9-10. PubMed ID: 6690689 [No Abstract] [Full Text] [Related] [Next] [New Search]